Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System Database (SNDS)

View ORCID ProfileElise Dumas, View ORCID ProfileLucie Laot, View ORCID ProfileFlorence Coussy, View ORCID ProfileBeatriz Grandal Rejo, View ORCID ProfileEric Daoud, View ORCID ProfileEnora Laas, Amyn Kassara, View ORCID ProfileAlena Majdling, View ORCID ProfileRayan Kabirian, View ORCID ProfileFloriane Jochum, View ORCID ProfilePaul Gougis, Sophie Michel, View ORCID ProfileSophie Houzard, View ORCID ProfileChristine Le Bihan-Benjamin, View ORCID ProfilePhilippe-Jean Bousquet, Judicaël Hotton, View ORCID ProfileChloé-Agathe Azencott, View ORCID ProfileFabien Reyal, View ORCID ProfileAnne-Sophie Hamy
doi: https://doi.org/10.1101/2022.03.14.22272286
Elise Dumas
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
2INSERM, U900, 75005 Paris, France
3MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elise Dumas
  • For correspondence: elise.dumas@curie.fr
Lucie Laot
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Lucie Laot
Florence Coussy
5Department of Medical Oncology, Institut Curie, University of Paris, 75005 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Florence Coussy
Beatriz Grandal Rejo
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Beatriz Grandal Rejo
Eric Daoud
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
6INRIA, DI/ENS, PSL Research University, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Eric Daoud
Enora Laas
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Enora Laas
Amyn Kassara
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alena Majdling
7Centre René Hughenin, Medical Oncology Department, 92210 Saint Cloud, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alena Majdling
Rayan Kabirian
7Centre René Hughenin, Medical Oncology Department, 92210 Saint Cloud, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rayan Kabirian
Floriane Jochum
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
8Department of gynecology, Strasbourg University Hospital, Strasbourg, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Floriane Jochum
Paul Gougis
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Paul Gougis
Sophie Michel
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sophie Houzard
9Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 92100 Boulogne-Billancourt, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sophie Houzard
Christine Le Bihan-Benjamin
9Health Data and Assessment, Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 92100 Boulogne-Billancourt, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Christine Le Bihan-Benjamin
Philippe-Jean Bousquet
10Aix Marseille Univ, Inserm, IRD, SESSTIM, Equipe Labellisée Ligue Contre le Cancer, 13005 Marseille, France
11Survey Data Science and Assessment Division, French National Cancer Institute (Institut National du Cancer INCa), 92100 Boulogne-Billancourt, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Philippe-Jean Bousquet
Judicaël Hotton
12Department of Surgery, Institut Jean Godinot, Reims, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chloé-Agathe Azencott
3MINES ParisTech, PSL Research University, CBIO-Centre for Computational Biology, 75006 Paris, France
13Institut Curie, PSL Research University, 75005 Paris, France
2INSERM, U900, 75005 Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Chloé-Agathe Azencott
Fabien Reyal
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
12Department of Surgery, Institut Jean Godinot, Reims, France
4Department of Surgical Oncology, Institut Curie, University of Paris, 75005, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Fabien Reyal
Anne-Sophie Hamy
1Residual Tumor & Response to Treatment Laboratory, RT2Lab, Translational Research Department, INSERM, U932 Immunity and Cancer, F-75005 Paris, France
7Centre René Hughenin, Medical Oncology Department, 92210 Saint Cloud, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Anne-Sophie Hamy
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Breast cancer (BC) is the most frequent cancer and the leading cause of cancer-related death in women. The French National Cancer Institute has created a national cancer cohort to promote cancer research and improve our understanding of cancer using the National Health Data System (SNDS). This cohort amalgamates all cancer sites, with no detailed separate data for early BC.

Objectives We describe the French Early Breast Cancer Cohort (FRESH).

Methods All French women aged 18 years or over, with early-stage BC newly diagnosed between January 1, 2011 and December 31, 2017, treated by surgery and registered in the general health insurance coverage plan were included in the cohort. Patients with suspected locoregional or distant metastases at diagnosis were excluded. BC treatments (surgery, chemotherapy, targeted therapy, radiotherapy, endocrine therapy), and diagnostic procedures (biopsy, cytology, imaging) were extracted from hospital discharge reports, outpatient care notes or pharmacy drug delivery data. BC subtype was inferred from the treatments received.

Results We included 235,368 patients with early BC in the cohort (median age: 60 years). BC subtype distribution was as follows: luminal (80.2%), triple-negative (TNBC, 9.5%); HER2+ (10.3%), or unidentifiable (n=44,388, 18.9% of the cohort). Most patients underwent radiotherapy (n=200,685, 85.3%) and endocrine therapy (n=165,655, 70.4%), and 38.3% (n=90,252) received chemotherapy. Treatments and care pathways are described.

Conclusion The FRESH Cohort is an unprecedented population-based resource facilitating future large-scale real-life studies aiming to improve care pathways and quality of care for BC patients.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

Elise Dumas received a PhD grant from the Ministere de lEnseignement Superieur et de la Recherche et de lInnovation, allocated to Ecole polytechnique (AMX). This study was also funded by Monoprix. The funder was not involved in study design, or in the collection, analysis, and interpretation of data, the writing of this article or the decision to submit it for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was conducted in the framework of a partnership between Institut Curie and the French INCa. It was performed in accordance with institutional and ethical rules concerning research using data from patients. The study was authorized by the French data protection agency (Commission nationale de linformatique et des libert&eacutes CNIL, under registration number 920017). Personal data were kept confidential, for all participants, by pseudoanonymizing the data. Written informed consent from the patients was not required, in accordance with French regulations

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted March 14, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System Database (SNDS)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System Database (SNDS)
Elise Dumas, Lucie Laot, Florence Coussy, Beatriz Grandal Rejo, Eric Daoud, Enora Laas, Amyn Kassara, Alena Majdling, Rayan Kabirian, Floriane Jochum, Paul Gougis, Sophie Michel, Sophie Houzard, Christine Le Bihan-Benjamin, Philippe-Jean Bousquet, Judicaël Hotton, Chloé-Agathe Azencott, Fabien Reyal, Anne-Sophie Hamy
medRxiv 2022.03.14.22272286; doi: https://doi.org/10.1101/2022.03.14.22272286
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
The French Early Breast Cancer Cohort (FRESH): a resource for breast cancer research and evaluations of oncology practices based on the French National Healthcare System Database (SNDS)
Elise Dumas, Lucie Laot, Florence Coussy, Beatriz Grandal Rejo, Eric Daoud, Enora Laas, Amyn Kassara, Alena Majdling, Rayan Kabirian, Floriane Jochum, Paul Gougis, Sophie Michel, Sophie Houzard, Christine Le Bihan-Benjamin, Philippe-Jean Bousquet, Judicaël Hotton, Chloé-Agathe Azencott, Fabien Reyal, Anne-Sophie Hamy
medRxiv 2022.03.14.22272286; doi: https://doi.org/10.1101/2022.03.14.22272286

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (524)
  • Anesthesia (125)
  • Cardiovascular Medicine (1430)
  • Dentistry and Oral Medicine (219)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (588)
  • Epidemiology (10321)
  • Forensic Medicine (6)
  • Gastroenterology (532)
  • Genetic and Genomic Medicine (2649)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (679)
  • Hematology (269)
  • HIV/AIDS (569)
  • Infectious Diseases (except HIV/AIDS) (12111)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (274)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2476)
  • Nursing (145)
  • Nutrition (380)
  • Obstetrics and Gynecology (496)
  • Occupational and Environmental Health (569)
  • Oncology (1330)
  • Ophthalmology (403)
  • Orthopedics (151)
  • Otolaryngology (238)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2415)
  • Public and Global Health (5025)
  • Radiology and Imaging (898)
  • Rehabilitation Medicine and Physical Therapy (532)
  • Respiratory Medicine (686)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (299)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)